#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary tuberculosis Pustular psoriasis Waldenstrom's macroglobulinaemia recurrent MELAS syndrome Cerebellar ataxia Superficial vein thrombosis Chronic graft versus host disease in skin Neonatal alloimmune thrombocytopenia Thymic carcinoma Lennox-Gastaut syndrome Pulmonary sarcoidosis Malignant oligodendroglioma Turner's syndrome Methylmalonic acidaemia Erythema multiforme More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic – Life with Disease Angiosarcoma – Basic Information Marginal zone lymphoma refractory – Trials in Disease Hyperoxaluria Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Stevens-Johnson syndrome – Basic Information Anaplastic thyroid cancer – Life with Disease Friedreich’s ataxia – Basic Information Usher’s syndrome – Basic Information Biotinidase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vx-264 Cpk850 Sacituzumab Tirumotecan Bms-986449-03 AGALSIDASE BETA Dog Epithelia Sulodexide Sulfur Hexafluoride Adezunap Metronidazole Polatuzumab Vedotin Ipratropium Bromide Utreloxastat Lixudebart Sulpiride Doxorubicin Hydrochloride Deupirfenidone Potassium Canrenoate Sodium Chloride Teprotumumab More therapies…

    Learn about Your Condition

    Measles Hyperhidrosis Diabetes insipidus Acute kidney injury Type 1 diabetes mellitus Cardiac amyloidosis Ligament sprain Chronic fatigue syndrome Vertebrobasilar stroke Krabbe's disease Angiosarcoma metastatic Candida infection Skin bacterial infection Encephalopathy neonatal MELAS syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pia Fondazione Di Culto E Religione Card G Panico

Pia Fondazione Di Culto E Religione Card G Panico

Via Pio X 4, Tricase, 73039, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Gemcitabine and Paclitaxel with Drug Combination for Patients with Advanced Pancreatic Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Gemcitabine Hydrochloride
    Italy

  • Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Treosulfan
    • Daunorubicin Hydrochloride
    • Gemtuzumab Ozogamicin
    Italy

  • Study on Axatilimab and Corticosteroids for Initial Treatment of Chronic Graft-Versus-Host Disease in Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Axatilimab
    • Methylprednisolone
    • Prednisone
    Austria Denmark France Germany Ireland Italy +2

  • Study on Avelumab and Cetuximab for Patients with Metastatic Colorectal Cancer Who Have Previously Received Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Avelumab
    • Cetuximab
    Italy

  • Study on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Olaparib
    Italy

  • Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Belinostat
    • Pralatrexate
    • Cyclophosphamide
    France Germany Hungary Italy Poland Spain

  • Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Daunorubicin Hydrochloride
    • Busulfan
    • Azacitidine
    Italy

  • Study on Preoperative Chemoradiotherapy with Capecitabine and Temozolomide for Patients with Locally Advanced Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Temozolomide
    • Capecitabine
    Italy

  • Study of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Calcium Folinate
    Italy

  • Study of Valproic Acid, Panitumumab, and Irinotecan for Patients with Metastatic Colorectal Cancer with RAS/BRAF Wild-Type

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Valproic Acid
    • Panitumumab
    • Irinotecan Hydrochloride Trihydrate
    Italy
Previous Page
1 2 3 4 5 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!